Kristof Roox
Overview
Pharmaceutical and life sciences companies often have to deal with complex patent litigation. They require help from someone with a pragmatic, creative approach, and this is Kristof Roox’s particular strength. Clients reach out to Kristof for his tenacity in the courtroom as well as his to-the-point counseling on every aspect of intellectual property law.
Career & Education
- Free University of Brussels (Vrije Universiteit Brussel), J.D., cum laude, licentiate degree law, 1994
- University of London (Queen Mary and Westfield College), LL.M., intellectual property law, 1996
- Heilig-Hartcollege, Maasmechelen, 1989
- Belgium
- Intellectual Property Council, section Industrial Propert, Belgian Government, FPS Economy
- Editorial Board, IRDI
- Board of Governors, University of Brussels Law Alumni
- Dutch
- English
- French
- German
Kristof Roox is regarded by one client as ‘the number one in Brussels.’
— Chambers Europe, 2020
Kristof's Insights
Press Coverage | 08.14.24
Client Alert | 6 min read | 07.25.24
Client Alert | 3 min read | 07.02.24
Client Alert | 4 min read | 06.26.24
Representative Matters
- Regularly represents several major international pharmaceutical companies in patent infringement and invalidity litigation.
- Represents several clients in parallel import cases.
- Represented a client in a dispute regarding a new type of shock absorber for cars.
- Represents a major Belgian cable network provider in one of the most important copyright cases in Belgium regarding “direct injection,” “simulcasting” and “all rights included” contracts.
- Represents an association of music festivals in a major dispute concerning copyright royalties and abuse of dominance.
- Represented the Belgian government in high-profile litigation concerning the alleged non-respect of several court orders.
- Represents software manufacturers in licensing disputes.
- Represents a client in a white collar crime / public procurement matter.
Kristof's Insights
Press Coverage | 08.14.24
Client Alert | 6 min read | 07.25.24
Client Alert | 3 min read | 07.02.24
Client Alert | 4 min read | 06.26.24
Recognition
- IAM 1000: Gold – Firms: Litigation and Transactions, 2024
- Chambers Europe: Belgium, Intellectual Property, 2006–2024
- Chambers Europe: Belgium, Life Sciences: Domestic, 2006–2020
- IAM Strategy 300: World leading IP strategist for Legal, Medical Devices and Pharmaceuticals/Life Sciences, 2024
Kristof's Insights
Press Coverage | 08.14.24
Client Alert | 6 min read | 07.25.24
Client Alert | 3 min read | 07.02.24
Client Alert | 4 min read | 06.26.24
Insights
International Litigation: Litigating Patents in Europe: A Whole New Ball Game
|01.10.24
Litigation Forecast 2024
- |
08.15.20
Crowell & Moring
Safe Harbors in Europe: An Update on the Research and Bolar Exemptions to Patent Infringement
|07.30.15
Nature Biotechnology, Vol. 33, No. 7
Counterfeit remains seized despite expiration of patent, decides Antwerp Judge
|02.19.15
Kluwer Patent Blog
Regulatory Forecast 2015: What Corporate Counsel Need to Know for the Coming Year
|01.31.15
a Crowell & Moring LLP publication
De Minimis in Belgian Patent Law
|01.01.15
I.R.D.I.
U.S. Law Firm Crowell & Moring Confirms Its Europe Expansion Through Its Brussel Office
|06.23.22
Leaders League
Crowell & Moring Adds Veteran Disputes Partner In Brussels From Allen & Overy
|06.22.22
The Global Legal Post
Practices
- Intellectual Property — Brussels Practice
- Dispute Resolution — Brussels Practice/IP
- Life Sciences — Brussels Practice
- Trademarks and Designs — Brussels Practice
- Copyright — Brussels Practice
- Copyright Counseling and Litigation
- Patents — Brussels Practice
- European Patents and Unified Patent Court — Brussels Practice
- Brussels Practice
- Technology, Media, and Telecommunications — Brussels Practice
- Health Care
- Financial Services
Industries
Kristof's Insights
Press Coverage | 08.14.24
Client Alert | 6 min read | 07.25.24
Client Alert | 3 min read | 07.02.24
Client Alert | 4 min read | 06.26.24